DealBreaker and DealBook on the bonus given to the CEO of Goldman Sachs (GS).

DealBreaker on the big bonus backlash and the backlash against the bonus backlash.

Andrew Ross Sorkin and Michael J. de la Merced in the New York Times on one private equity firm that has committed $37 billion to investments in the last week.

Eddy Elfenbein at Crossing Wall Street has an open letter to shareholders of Biomet (BMET) in regards to the proposed going private transaction.

FT Alphaville and DealBook pick up on comments by Stephen Schwarzman on competitive bidding on buyouts and the likelihood of ‘a flood’ of alternative investment firms going public.

Mark Gongloff at MarketBeat on why they still call countries like Thailand, ’emerging markets.’

Accrued Interest on the complicated nature of ‘beta’ when discussing bonds.

Barry Ritholtz at the Big Picture on whether sentiment is too bullish or too bearish.

Jeff Miller at A Dash of Insight on cognitive bias and punditry.

Paul Kedrosky at Infectious Greed on men closing the life expectancy gap with women.

The Economist on the increasingly prominent role “hedonimetrists” are playing in economics.

Bruce Bower at Science News on evidence that shows people with positive moods show greater resistance to getting colds.

Mmmm…Sorghum beer. (AP via USA Today)

You can always stay up-to-date with all of our posts via our feed.